Srinagar, Nov 25 (IANS) In a significant step to bolster healthcare infrastructure across Jammu and Kashmir, the government has initiated the process of procuring Linear Accelerator (LINAC), a state-of-the-art medical equipment for cancer treatment for the Sher-e-Kashmir Institute of Medical Sciences (SKIMS), Soura, an official statement said.
LINAC is a sophisticated device, having an integrated CT Scanner or an integrated MRI for image guidance, that generates high-energy X-rays and electron beams, which can precisely destroy cancer cells while minimising damage to surrounding healthy tissues.
LINAC is a cornerstone in cancer treatment and fundamental to obtaining the highest rates of curing cancer in the majority of patients suffering from it.
Speaking on this significant development, Jammu and Kashmir Minister for Health and Medical Education, Social Welfare and Education, Sakeena Itoo, underlined that the government led by Chief Minister Omar Abdullah is committed to providing advanced healthcare services to the people of the Union Territory.
“The health sector is a priority for the government and we are determined to provide world-class medical facilities to people here,” Sakeena said.
“These measures have been taken in that direction and is one among many efforts the government has initiated for enhancing cancer treatment facilities across J&K.”
The Minister highlighted that the government’s initiative to procure LINAC is expected to significantly improve cancer treatment outcomes in Jammu and Kashmir.
Sakeena Itoo added that patients, especially those belonging to economically weaker sections, will no longer need to travel outside for advanced cancer treatment after the establishment of this facility in SKIMS.
The Minister also said that this facility will reduce the financial burden on families going through tough times during the treatment phase of their patients.
LINAC will be procured by SKIMS for the State Cancer Institute, under the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke scheme through J&K Medical Supplies Corporation Limited for an estimated cost of Rs 29 crore.
–IANS
zi/khz
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
